T2* cardiovascular magnetic resonance in the management of thalassemia patients in Oman.
作者信息
Daar Shahina, Pathare Anil V, Jain Rajeev, Zadjali Shoaib Al, Pennell Dudley J
出版信息
Haematologica. 2009 Jan;94(1):140-1. doi: 10.3324/haematol.13845. Epub 2008 Nov 10.
Abstract
摘要
相似文献
1
T2* cardiovascular magnetic resonance in the management of thalassemia patients in Oman.阿曼地中海贫血患者管理中的T2*心血管磁共振成像
Haematologica. 2009 Jan;94(1):140-1. doi: 10.3324/haematol.13845. Epub 2008 Nov 10.
2
Standardized T2* map of a normal human heart to correct T2* segmental artefacts; myocardial iron overload and fibrosis in thalassemia intermedia versus thalassemia major patients and electrocardiogram changes in thalassemia major patients.用于校正T2*节段伪影的正常人体心脏标准化T2*图；中间型地中海贫血与重型地中海贫血患者的心肌铁过载和纤维化以及重型地中海贫血患者的心电图变化。
Hemoglobin. 2008;32(1-2):97-107. doi: 10.1080/03630260701879514.
3
Relationship of magnetic resonance imaging estimation of myocardial iron to left ventricular systolic and diastolic function in thalassemia.地中海贫血患者中心肌铁磁共振成像评估与左心室收缩和舒张功能的关系
JACC Cardiovasc Imaging. 2008 Sep;1(5):572-8. doi: 10.1016/j.jcmg.2008.04.005.
4
Development of a novel optimized breathhold technique for myocardial T2 measurement in thalassemia.一种用于地中海贫血心肌T2测量的新型优化屏气技术的开发。
J Magn Reson Imaging. 2006 Sep;24(3):580-5. doi: 10.1002/jmri.20681.
5
Cardiac magnetic resonance imaging R2* assessments and analysis of historical parameters in patients with transfusion-dependent thalassemia.输血依赖型地中海贫血患者的心脏磁共振成像R2*评估及历史参数分析
Haematologica. 2007 Jan;92(1):131-2. doi: 10.3324/haematol.10455.
6
Uses and limitations of serum ferritin, magnetic resonance imaging T2 and T2* in the diagnosis of iron overload and in the ferrikinetics of normalization of the iron stores in thalassemia using the International Committee on Chelation deferiprone/deferoxamine combination protocol.血清铁蛋白、磁共振成像T2及T2*在使用国际螯合委员会去铁酮/去铁胺联合方案诊断地中海贫血中铁过载及铁储存正常化的铁动力学方面的用途及局限性
Hemoglobin. 2009;33(5):312-22. doi: 10.3109/03630260903213231.
7
Clinical silent cerebral infarct (SCI) in patients with thalassemia diseases assessed by magnetic resonance imaging (MRI).通过磁共振成像（MRI）评估地中海贫血疾病患者的临床无症状脑梗死（SCI）。
J Med Assoc Thai. 2008 Jun;91(6):889-94.
8
Magnetic resonance imaging during management of patients with transfusion-dependent thalassemia: a single-center experience.输血依赖型地中海贫血患者管理期间的磁共振成像：单中心经验。
Radiol Med. 2018 Aug;123(8):572-576. doi: 10.1007/s11547-018-0889-0. Epub 2018 Apr 16.
9
Clinical and imaging findings in thalassemia patients with extramedullary hematopoiesis.地中海贫血患者骨髓外造血的临床和影像学表现。
Clin Imaging. 2012 Sep-Oct;36(5):475-82. doi: 10.1016/j.clinimag.2011.11.019. Epub 2012 Jun 8.
10
Quantification of liver iron overload by T2 quantitative magnetic resonance imaging in thalassemia: impact of chronic hepatitis C on measurements.地中海贫血中通过T2定量磁共振成像对肝脏铁过载进行定量分析：慢性丙型肝炎对测量结果的影响。
J Pediatr Hematol Oncol. 1999 Mar-Apr;21(2):142-8. doi: 10.1097/00043426-199903000-00011.
引用本文的文献
1
Correlation study between magnetic resonance imaging-quantitated cardiac iron deposition and left ventricular function in patients with β-thalassemia major in China.中国重型β地中海贫血患者磁共振成像定量心脏铁沉积与左心室功能的相关性研究
Sci Prog. 2025 Jan-Mar;108(1):368504251318196. doi: 10.1177/00368504251318196.
2
The Importance of Cardiac T2* Magnetic Resonance Imaging for Monitoring Cardiac Siderosis in Thalassemia Major Patients.心脏 T2* 磁共振成像在监测重型地中海贫血患者心脏铁过载中的重要性。
Tomography. 2021 Apr 18;7(2):130-138. doi: 10.3390/tomography7020012.
3
Understanding Iron Metabolism: Lessons from Transfusion-dependent Thalassemia.了解铁代谢：来自输血依赖型地中海贫血的经验教训。
Oman Med J. 2018 Jan;33(1):1-2. doi: 10.5001/omj.2018.01.
4
Evaluation of Glutathione-S-Transferase P1 Polymorphism and its Relation to Bone Mineral Density in Egyptian Children and Adolescents with Beta-Thalassemia Major.埃及重型β地中海贫血儿童和青少年中谷胱甘肽-S-转移酶P1基因多态性及其与骨密度关系的评估
Mediterr J Hematol Infect Dis. 2016 Jan 1;8(1):e2016004. doi: 10.4084/MJHID.2016.004. eCollection 2016.
5
On improvement in ejection fraction with iron chelation in thalassemia major and the risk of future heart failure.地中海贫血症患者铁螯合治疗对射血分数的改善作用和未来心力衰竭风险。
J Cardiovasc Magn Reson. 2011 Sep 12;13(1):45. doi: 10.1186/1532-429X-13-45.
6
Rapid iron loading in heart and liver in a patient with transfusion dependent thalassaemia after brief poor compliance with iron chelation therapy.一名依赖输血的地中海贫血患者在短暂不依从铁螯合治疗后，心脏和肝脏中铁快速蓄积。
Sultan Qaboos Univ Med J. 2010 Dec;10(3):401-4. Epub 2010 Nov 14.
7
Deferasirox (Exjade) significantly improves cardiac T2* in heavily iron-overloaded patients with beta-thalassemia major.地拉罗司（Exjade）可显著改善重型β-地中海贫血患者的心脏 T2*。
Ann Hematol. 2010 Apr;89(4):405-9. doi: 10.1007/s00277-009-0838-z. Epub 2009 Oct 2.
本文引用的文献
1
Onset of cardiac iron loading in pediatric patients with thalassemia major.重型地中海贫血患儿心脏铁负荷的发生
Haematologica. 2008 Jun;93(6):917-20. doi: 10.3324/haematol.12513. Epub 2008 Apr 15.
2
Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction.重型地中海贫血联合螯合疗法治疗重度心肌铁沉着症伴左心室功能障碍。
J Cardiovasc Magn Reson. 2008 Feb 25;10(1):12. doi: 10.1186/1532-429X-10-12.
3
A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance.一项使用心血管磁共振评估去铁胺与去铁酮联合治疗对重型地中海贫血患者心肌铁影响的随机、安慰剂对照、双盲试验。
Circulation. 2007 Apr 10;115(14):1876-84. doi: 10.1161/CIRCULATIONAHA.106.648790. Epub 2007 Mar 19.
4
Glutathione S-transferase M1 gene polymorphisms are associated with cardiac iron deposition in patients with beta-thalassemia major.谷胱甘肽S-转移酶M1基因多态性与重型β地中海贫血患者心脏铁沉积有关。
Hemoglobin. 2006;30(2):251-6. doi: 10.1080/03630260600642575.
5
Low serum ferritin levels are misleading for detecting cardiac iron overload and increase the risk of cardiomyopathy in thalassemia patients. The importance of cardiac iron overload monitoring using magnetic resonance imaging T2 and T2*.低血清铁蛋白水平在检测地中海贫血患者的心脏铁过载时具有误导性，并增加了心肌病的风险。使用磁共振成像T2和T2*监测心脏铁过载的重要性。
Hemoglobin. 2006;30(2):219-27. doi: 10.1080/03630260600642542.
6
Myocardial iron loading in patients with thalassemia major on deferoxamine chelation.接受去铁胺螯合治疗的重型地中海贫血患者的心肌铁负荷
J Cardiovasc Magn Reson. 2006;8(3):543-7. doi: 10.1080/10976640600698155.
7
Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload.去铁胺与去铁酮联合治疗重型β地中海贫血输血性铁过载患者。
Ann Hematol. 2006 May;85(5):315-9. doi: 10.1007/s00277-005-0075-z. Epub 2006 Feb 1.
8
Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major.接受去铁胺或去铁酮治疗的重型地中海贫血患者的心脏发病率和死亡率。
Blood. 2006 May 1;107(9):3733-7. doi: 10.1182/blood-2005-07-2933. Epub 2005 Dec 22.
9
Evaluation of iron overload.铁过载评估
Br J Haematol. 2004 Mar;124(6):697-711. doi: 10.1111/j.1365-2141.2004.04838.x.
10
Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload.心血管T2*（T2*）磁共振成像用于心肌铁过载的早期诊断。
Eur Heart J. 2001 Dec;22(23):2171-9. doi: 10.1053/euhj.2001.2822.
Zotero 插件